Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

被引：0
|
作者：
Akhtar, Saad
Al-Kofide, Amani
Bakshi, Nasir
Shamayel, Mohammed
Khafaga, Yasser
Al-Sweedan, Suleimman
Elhassan, Tusneem
Rauf, M. S.
Maghfoor, Irfan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2794
引用
收藏
页数：3
相关论文
共 45 条
  • [21] Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    von Tresckow, Bastian
    Boell, Boris
    Behringer, Karolin
    Diehl, Volker
    Eich, Hans Theodor
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2857 - +
  • [22] Nodular lymphocyte-predominant Hodgkin lymphoma and clinical impact of its variant histology: a clinicopathologic study from tertiary cancer centre in India
    Mulchandani, Nikita J.
    Kurian, Ann
    Subramanyan, Annapurneswari
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 141 - 150
  • [23] Nodular lymphocyte-predominant Hodgkin lymphoma and clinical impact of its variant histology: a clinicopathologic study from tertiary cancer centre in India
    Nikita J. Mulchandani
    Ann Kurian
    Annapurneswari Subramanyan
    Journal of Hematopathology, 2022, 15 : 141 - 150
  • [24] High dose chemotherapy and auto-SCT for nodular lymphocyte-predominant Hodgkin lymphoma: Single institution results of sixteen patients treated with and without rituximab containing salvage chemotherapy
    Akhtar, S.
    Rauf, M. S.
    Elhassan, T. A. M.
    Maghfoor, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S292 - S293
  • [25] PET-2-guided escalated BEACOPP for patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
    Eichenauer, D. A.
    Kreissl, S.
    Buehnen, I.
    Goergen, H.
    Hartmann, S.
    Fuchs, M.
    von Tresckow, B.
    Engert, A.
    Borchmann, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 87 - 88
  • [26] Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups
    Shankar, Ananth G.
    Roques, Gaelle
    Kirkwood, Amy A.
    Lambilliotte, Anne
    Freund, Katja
    Leblanc, Thierry
    Hayward, Janis
    Abbou, Samuel
    Ramsay, Alan D.
    Schmitt, Claudine
    Gorde-Grosjean, Stephanie
    Pacquement, Helene
    Haouy, Stephanie
    Boudjemaa, Sabah
    Aladjidi, Nathalie
    Hall, Georgina W.
    Landman-Parker, Judith
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (01) : 106 - 115
  • [27] Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL): A Case Series of Consecutive Patients Treated at a Tertiary Care Hospital in Saudi Arabia from 2005-2015
    Al-Sweedan, S.
    Siddiqui, K.
    Jafri, R.
    Al-Kofide, A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S195 - S196
  • [28] Lymphocyte-Predominant Hodgkin Lymphoma Variant: Long Term Outcome. Data From The Lh-2004 Protocol Of The Italian Association Of Pediatric Hematology And Oncology (Aieop)
    Mazzocco, M.
    Mura, R.
    De Santis, R.
    Casini, T.
    Porta, F.
    Pierani, P.
    Cellini, M.
    Sau, A.
    Verzegnassi, F.
    Perruccio, K.
    Cesaro, S.
    Bertolini, P.
    Pericoli, R.
    Sperli, D.
    Mascarin, M.
    Burnelli, R.
    KLINISCHE PADIATRIE, 2020, 232 (02): : 84 - 84
  • [29] Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Buehnen, Ina
    Pluetschow, Annette
    Kobe, Carsten
    Dietlein, Markus
    Wendtner, Clemens-Martin
    Thorspecken, Sven
    Topp, Max S.
    Mauser, Mareike
    von Tresckow, Bastian
    Fuchs, Michael
    Borchmann, Peter
    Engert, Andreas
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 801 - 804
  • [30] LONG-TERM OUTCOME OF PATIENTS WITH NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA TREATED WITHIN THE RANDOMIZED HD7-HD15 TRIALS: AN ANALYSIS FROM THE GERMAN HODGKIN STUDY GROUP
    Eichenauer, D. A.
    Pluetschow, A.
    Fuchs, M.
    von Tresckow, B.
    Diehl, V.
    Borchmann, P.
    Engert, A.
    HAEMATOLOGICA, 2017, 102 : 82 - 82
12345